TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...
As of Friday, February 27, Fulgent Genetics, Inc.’s FLGT share price has dipped by 31.34%, which has investors questioning if this is right time to buy.
With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...
Use of AI can be a controversial subject, but in many ways, it's improving patient's experiences and helping doctors detect problems they can't see with the human eye.
The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial ...
"Looksmaxxing" may be a phrase that you've heard in the past few weeks, and this extreme trend has some surprising origins in ...
A major study found that men with the highest blood levels of PFAS — the "forever chemicals" in cookware, food packaging, and ...
The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.
Advancing Research, Awareness, and Targeted Youth Advocacy for Women Diagnosed with Breast Cancer Before Age 40 DENVER, ...
Jacobin on MSNOpinion

Let Them Eat Patents

Today roughly 25 percent of the global population works the land. Their grueling labor feeds the remaining 75 percent. The ...